AAAAAA

   
Results: 1-17 |
Results: 17
LOW MORBIDITY AND NO MORTALITY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND MITOXANTRONE PLUS AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT FOR HIGH-RISK BREAST-CANCER PATIENTS
Authors: KROGER N KRUGER WH GIESEKING F JAENICKE F SCHULTZE W FUSS H MOBUS V KONIGSMANN M BERDEL WE SCHAFERECKERT K WANDT H METZNER B ILLIGER HJ FRICKHOFEN N WULF G WORMANN B KOLBE K HOSSFELD DK MAAS H JONAT W ZANDER AR
Citation: N. Kroger et al., LOW MORBIDITY AND NO MORTALITY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA AND MITOXANTRONE PLUS AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT FOR HIGH-RISK BREAST-CANCER PATIENTS, European journal of cancer, 34, 1998, pp. 92-92
CYCLOPHOSPHAMIDE THIOTEPA/MITOXANTRONE WITH AUTOLOGOUS STEM-CELL RESCUE FOR HIGH-RISK STAGE-II AND STAGE-III BREAST-CANCER/
Authors: KRUGER WH KROGER N KONIGMANN M BERDEL WE FUSS H SCHULTZE W GIESEKING F SCHAFERECKART K MOBUS V FRICKHOFEN N WANDT H ILLIGER HJ METZNER B KOLBE K WORMANN B TRUMPER L HUBER C MAASS H JONAT W ZANDER AR
Citation: Wh. Kruger et al., CYCLOPHOSPHAMIDE THIOTEPA/MITOXANTRONE WITH AUTOLOGOUS STEM-CELL RESCUE FOR HIGH-RISK STAGE-II AND STAGE-III BREAST-CANCER/, Bone marrow transplantation, 22, 1998, pp. 31-31
TUMOR-CELLS IN G-CSF-MOBILIZED STEM-CELLS OF WOMEN WITH HIGH-RISK BREAST-CANCER
Authors: KRUGER WH TOGEL F FRERK O HENNINGS S KROGER N ZANDER AR
Citation: Wh. Kruger et al., TUMOR-CELLS IN G-CSF-MOBILIZED STEM-CELLS OF WOMEN WITH HIGH-RISK BREAST-CANCER, Bone marrow transplantation, 21, 1998, pp. 220-220
LOW TOXICITY OF HIGH-DOSE CTM FOLLOWED BY AUTOLOGOUS STEM-CELL REINFUSION FOR HIGH-RISK BREAST-CANCER
Authors: KRUGER WH KROGER N KOLBE K HUBER C GIESEKING F JANICKE F KONIGSMANN M BERDEL WE KERSCHGENS C MAYR AC SCHAFERECKERT K WANDT H SCHULTZE W FUSS H METZNER B ILLIGER HJ FRICKHOFEN N MOBUS V HOSSFELD DK JONAT W ZANDER AR
Citation: Wh. Kruger et al., LOW TOXICITY OF HIGH-DOSE CTM FOLLOWED BY AUTOLOGOUS STEM-CELL REINFUSION FOR HIGH-RISK BREAST-CANCER, Bone marrow transplantation, 21, 1998, pp. 221-221
LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING MARROW OR BLOOD STEM-CELL TRANSPLANTATION
Authors: KRUGER WH RUSSMANN BC KROGER N EKOPF N FUCHS N RENGES H BIELING P SOBOTTKA I ERTTMANN R KABISCH H ZANDER AR
Citation: Wh. Kruger et al., LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING MARROW OR BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 531-531
CYTOKINE-INFLUENCE ON SPECIFICITY OF CYTOKERATIN-19 RTPCR FOR CANCER CELL DETECTION
Authors: KRUGER WH JUNG R HENNINGS S KROGER N ZANDER AR
Citation: Wh. Kruger et al., CYTOKINE-INFLUENCE ON SPECIFICITY OF CYTOKERATIN-19 RTPCR FOR CANCER CELL DETECTION, Bone marrow transplantation, 21, 1998, pp. 639-639
DETECTION OF MICROMETASTATIC CANCER-CELLS WITH AND WITHOUT IMMUNOMAGNETIC ENRICHMENT
Authors: KRUGER WH TOGEL F HENNINGS S KROGER N ZANDER AR
Citation: Wh. Kruger et al., DETECTION OF MICROMETASTATIC CANCER-CELLS WITH AND WITHOUT IMMUNOMAGNETIC ENRICHMENT, Bone marrow transplantation, 21, 1998, pp. 640-640
NONTRANSFERRIN-BOUND IRON IN SERUM OF PATIENTS RECEIVING BONE-MARROW TRANSPLANTS
Authors: DURKEN M NIELSEN P KNOBEL S FINCKH B HERRNRING C DRESOW B KOHLSCHUTTER B STOCKSCHLADER M KRUGER WH KOHLSCHUTTER A ZANDER AR
Citation: M. Durken et al., NONTRANSFERRIN-BOUND IRON IN SERUM OF PATIENTS RECEIVING BONE-MARROW TRANSPLANTS, Free radical biology & medicine, 22(7), 1997, pp. 1159-1163
ANTIMYCOTIC THERAPY WITH LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: KRUGER WH RUSSMANN BC KROGER N EKOPF N FUCHS N SOBOTTKA I ERTTMANN R KABISCH H ZANDER AR
Citation: Wh. Kruger et al., ANTIMYCOTIC THERAPY WITH LIPOSOMAL AMPHOTERICIN-B FOR PATIENTS UNDERGOING BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 4414-4414
ASHAP SALVAGE THERAPY FOR RECURRENT AND REFRACTORY HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL)
Authors: HANEL M HOFFKNECHT MM PETERS SO FIEDLER F HANEL A KRUGER WH ZELLER W BRAUMANN D ILLIGER HJ METZNER B SCHUBERT JC SCHMITZ N WEH HJ KROGER N ZANDER AR
Citation: M. Hanel et al., ASHAP SALVAGE THERAPY FOR RECURRENT AND REFRACTORY HODGKINS-DISEASE (HD) AND NON-HODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 4559-4559
PDGF MEDIATES A NEURON-ASTROCYTE INTERACTION IN THE DEVELOPING RETINA
Authors: FRUTTIGER M CALVER AR KRUGER WH MUDHAR HS MICHALOVICH D TAKAKURA N NISHIKAWA SI RICHARDSON WD
Citation: M. Fruttiger et al., PDGF MEDIATES A NEURON-ASTROCYTE INTERACTION IN THE DEVELOPING RETINA, Neuron, 17(6), 1996, pp. 1117-1131
DIFFERENTIAL EXPRESSION OF RAB3 ISOFORMS IN OLIGODENDROCYTES AND ASTROCYTES
Authors: MADISON DL KRUGER WH KIM T PFEIFFER SE
Citation: Dl. Madison et al., DIFFERENTIAL EXPRESSION OF RAB3 ISOFORMS IN OLIGODENDROCYTES AND ASTROCYTES, Journal of neuroscience research, 45(3), 1996, pp. 258-268
EXPRESSION OF ADHESION MOLECULES ON CD34-MARROW AND PERIPHERAL-BLOOD PRIOR AND AFTER STIMULATION WITH G-CSF IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES OR SOLID TUMORS( CELLS IN BONE)
Authors: KROGER N ZELLER W KRUGER WH STOCKSCHLADER M DIERLAMM J HUMMEL K HOSSFELD DK ZANDER AR
Citation: N. Kroger et al., EXPRESSION OF ADHESION MOLECULES ON CD34-MARROW AND PERIPHERAL-BLOOD PRIOR AND AFTER STIMULATION WITH G-CSF IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES OR SOLID TUMORS( CELLS IN BONE), Experimental hematology, 24(9), 1996, pp. 146-146
PURGING AND PROGENITOR SELECTION BY CD34-SEPARATION - A COMPARISON OF3 DEVICES()
Authors: KRUGER WH GRUBER M STOCKSCHLADER M HENNINGS S FEHSE N SCHLEIMER B HASSAN HT GUTENSOHN K LOLIGER C ZANDER AR
Citation: Wh. Kruger et al., PURGING AND PROGENITOR SELECTION BY CD34-SEPARATION - A COMPARISON OF3 DEVICES(), Experimental hematology, 24(9), 1996, pp. 603-603
CYTOKERATIN-19 REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND CELL-CULTURE DETECTION OF CANCER-CELLS IN G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS OF WOMEN WITH BREAST-CANCER
Authors: KRUGER WH HENNINGS S ASCHENBRENNER M GRUBER M STOCKSCHLADER M GUTENSOHN K LOLIGER C GIESEKING F JONAT W ZANDER AR
Citation: Wh. Kruger et al., CYTOKERATIN-19 REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND CELL-CULTURE DETECTION OF CANCER-CELLS IN G-CSF-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS OF WOMEN WITH BREAST-CANCER, Blood, 88(10), 1996, pp. 999-999
INHIBITION OF CFU-C GROWTH BY VP-16 CONTAINING PLASMA SAMPLES OBTAINED FROM PATIENTS AFTER CONDITIONING THERAPY FOR BONE-MARROW TRANSPLANTATION
Authors: KRUGER WH BERGER C MROSS KB BEWERMEIER P PICHLMEIER U STOCKSCHLADER M SCHLEIMER B ZANDER AR
Citation: Wh. Kruger et al., INHIBITION OF CFU-C GROWTH BY VP-16 CONTAINING PLASMA SAMPLES OBTAINED FROM PATIENTS AFTER CONDITIONING THERAPY FOR BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(1), 1995, pp. 9-15
EXPERIENCE WITH LIPOSOMAL AMPHOTERICIN-B IN 60 PATIENTS UNDERGOING HIGH-DOSE THERAPY AND BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: KRUGER WH STOCKSCHLADER M RUSSMANN BC HOFFKNECHT MM SOBOTTKA I KROGER N ZANDER AR
Citation: Wh. Kruger et al., EXPERIENCE WITH LIPOSOMAL AMPHOTERICIN-B IN 60 PATIENTS UNDERGOING HIGH-DOSE THERAPY AND BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Blood, 86(10), 1995, pp. 3800-3800
Risultati: 1-17 |